Bioxytran (BIXT) Gross Profit (QoQ) (2010 - 2018)
Bioxytran (BIXT) Gross Profit (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 730.88% |
| Mar 31, 2018 | 70.69% |
| Dec 31, 2017 | -108.23% |
| Sep 30, 2017 | 298.93% |
| Jun 30, 2017 | 421.89% |
| Mar 31, 2017 | -117.46% |
| Dec 31, 2016 | -43.23% |
| Sep 30, 2016 | 71.03% |
| Jun 30, 2016 | 150.02% |
| Mar 31, 2016 | 406.52% |
| Dec 31, 2015 | -111.17% |
| Sep 30, 2015 | -3.78% |
| Jun 30, 2015 | -6.81% |
| Mar 31, 2015 | 161.82% |
| Dec 31, 2014 | -1,178.75% |
| Sep 30, 2014 | -72.18% |
| Jun 30, 2014 | -83.24% |
| Mar 31, 2014 | 122.81% |
| Dec 31, 2013 | 376.77% |
| Sep 30, 2013 | -73.75% |